Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00829_DB06414> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00829_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00829_DB06414 label "DDI between Diazepam and Etravirine - Diazepam (a CYP21C9 and CYP3A4 substrate), when administered concomitantly with etravirine, may experience an increase (via CYP21C9 inhibition) or a decrease(via CYP3A4 induction) in serum concentration. Overall clinical significance is unknown. It is recommended to monitor diazepam therapy. [drugbank_resource:DB00829_DB06414]" assertion.
- drugbank_resource:DB00829_DB06414 identifier "drugbank_resource:DB00829_DB06414" assertion.
- drugbank_resource:DB00829_DB06414 title "DDI between Diazepam and Etravirine - Diazepam (a CYP21C9 and CYP3A4 substrate), when administered concomitantly with etravirine, may experience an increase (via CYP21C9 inhibition) or a decrease(via CYP3A4 induction) in serum concentration. Overall clinical significance is unknown. It is recommended to monitor diazepam therapy." assertion.